News and Insights for Psychiatric Pharmacists

Collaborative practice agreements permit clinical pharmacists to provide expanded healthcare services to patients. Learn more in this 11-minute video.

There is an unmet need for fast-acting, effective pharmacotherapies for PPD. Learn about potential benefits and drawbacks to available treatments during this free webinar. #CE #virtual #psychpharmacy #PPD

Time is running out to register for the live event! Register today for this 2-day, virtual event, and join us for sessions Oct. 2-3. Recordings will be available for any sessions that registrants are unable to attend live.

The 10/17/24 #JournalClub article 2 presented "A Retrospective Review of Intramuscular Olanzapine and Parenteral Benzodiazepine Coadministration in the Emergency Department." The recording is available free to all AAPP members.

Last week, the Senate passed a reauthorization of the SUPPORT Act in a rare show of bipartisanship. The SUPPORT Act reauthorizes key prevention, treatment and recovery programs for patients with substance use disorder, including programs to support the behavioral health workforce. Among the reauthorized programs are the Substance Use Disorder Treatment and Recovery (STAR) Loan Repayment Program, helping bolster the workforce by providing loan repayment opportunities for SUD treatment and recovery providers in the face of severe workforce shortages — as well as critical recovery efforts through the Building Communities of Recovery (BCOR) program and comprehensive opioid recovery centers. The bill now heads to President Trump’s desk for his signature.

Initiation and Dose of Methadone Monotherapy vs Combination Therapy, 2015 to 2023

Retention rates and cost-effectiveness of telehealth vs. in-person buprenorphine treatment for opioid use disorder (OUD)

The application window for AAPP Awards and Fellowship are rapidly closing.

Applications for AAPP Awards and Fellowship are now open! Nominate yourself, a colleague, mentor, and/or rising stars as we spotlight pharmacy excellence.

AAPP has elected three members to the 2026-2028 Board of Directors. Congratulations to Drs. Cunningham, Campbell, and DiPaula!

The AAPP membership has elected Drs. Austin Campbell, Julie Cunningham and Bethany DiPaula to the 2026-2028 Board of Directors.

The AAPP Foundation will be offering Mental Health First Aid (MHFA) in the blended, virtual format on November 3! There is no cost to attend thanks to the bequest of Kim Tallian, and the class is limited to 30 participants. Register before the Sept. 24 deadline!

This document features high-level key takeaways from the May 2025 workshop.

AAPP’s free resource document on Methamphetamine Use Disorder provides information on screening, diagnosis, intoxication, withdrawal, treatment, co-occurring psychiatric disorders, special populations, and harm reduction strategies.

Calling all psychiatric pharmacist rising stars. Nominate yourself or others for the AAPP Early Practitioner Award designed to recognizes future leaders within AAPP and Psychiatric Pharmacy. Nominations close 10/1/2025.

Calling all psychiatric pharmacist rising stars. Nominate yourself or others for the AAPP Early Practitioner Award designed to recognizes future leaders within AAPP and Psychiatric Pharmacy. Nominations close 10/1/2025.

During this complimentary, grant-funded webinar, participants will learn about the potential benefits and drawbacks of available PPD treatments – including newer NAS medications. Register today and earn 1 hour of ACPE credit upon webinar completion.

The primary goal of the TNT PC-TEAM fellowship is to provide mentorship and teaching skills in the area of addiction medicine. Trainees will learn in both small and large group settings, with a focus on how to teach information and skills learned to providers in their region. The target audiences for the program are MDs, DOs, NPs and PAs. Learn more and apply by Oct. 31, 2025.

AAPP submitted comments on CMS’s CY 2026 Physician Fee Schedule Proposed Rule, encouraging the agency to strengthen behavioral health integration in primary care, expand telehealth flexibilities, and proceed cautiously with proposed changes to the 340B program.

AAPP’s new policy statements and briefs are rooted in evidence and AAPP’s mission. See how you can use them to advocate.

Are you involved in PPD management? If so, this CE is for you. Ensure you're up to date on the benefits and drawbacks to available treatments. #CE #virtual #psychpharmacy #PPD

AAPP Board member Danielle Stutzman, PharmD, BCPP, represented psychiatric pharmacy in expressing concerns about study's potential to perpetuate stigmatization of vaccines and, in particular, ASD.

BPS is requesting applicants to serve as panelists for standard setting for the specialty certification in Pain Management Pharmacy (BCPMP) examination. Standard setting is the process by which the passing standard (cut score) for the examination is set. Along with the results of statistical analysis, the expertise of subject matter experts in the practice area is critical for establishing a meaningful and fair passing standard. If selected, participation will consist of one 7-hour meeting (on November 4, 2025) via web conference in which you will engage in a review exercise with a representative form of the BCPMP examination, along with a panel of around fifteen other standard setting judges. If you are interested in participating, please submit your application by September 30, 2025. All selected volunteers will be notified after this date.

Exams can be daunting. Let us help! Register for the Developing Effective Test-Taking Skills webinar to sharpen your skills. #BCPP #examprep #psychpharmacy #AAPP

AAPP submitted comments on CMS’s CY 2026 Physician Fee Schedule Proposed Rule, encouraging the agency to strengthen behavioral health integration in primary care, expand telehealth flexibilities, and proceed cautiously with proposed changes to the 340B program. AAPP also responded to an embedded request for information on prescription drug monitoring programs (PDMP) requirements and as always, took the opportunity to encourage CMS to recognize psychiatric pharmacists as qualified health care professionals as well as create payment pathways for pharmacist-provided comprehensive medication management.

Carolanne Wartman, PharmD, BCPS, BCPP (she/her) discussing asking, advocating, and creating inclusive environments for LGBTQIA+ patients.

AAPP Student Chapters: This is your chance to get funding for your activities! Apply by Sept. 30 to receive up to $6,000.

During this complimentary, grant-funded webinar, participants will gain insight into the barriers to effective psychotropic LAI use and explore current research. Register today and earn 1 hour of ACPE credit upon webinar completion.

Approximately 60% of depression is treated in the primary care setting. Psychiatric pharmacists can utilize their knowledge and training to assist primary care providers in treating mental illness. Watch this video to learn more.

Nominate living legacies for the Saklad Award. Recognize a lifetime of impact & excellence by nominating a senior psychiatric pharmacy practitioner who has achieved a level of professional distinction.

The 10/31/24 #JournalClub article 1 presented "Ketamine for treatment-resistant major depressive disorder: Double-blind active-controlled crossover study." The recording is available free to all AAPP members.

Improve your peer review skills! Discover the components to evaluate, the role of the peer reviewer, the skills necessary to critically evaluate a manuscript, and how to provide feedback to authors and journal editors.

Earn 10 hours of ACPE and BCPP credit (if eligible) during the AAPP Summit, Oct. 2-3, 2025! Topics range from the treatment of agitation in high-risk patients to new migraine treatments. Review the full schedule and register today for $160 (members).

AAPP's pharmacist toolkit on Xylazine is intended to highlight both the evidence base available as well as strategies of clinical decision making used by expert clinicians.

A serial cross-sectional study.

Information about the impact of fentanyl-related overdose in neurological outcomes after cardiac arrest (CA) compared with other etiologies of CA is limited.

A triple-blind, double-dummy, randomized control trial.

Recognize change-makers who have impacted patient access to care and/or the profession of psychiatric pharmacy through their advocacy with policymakers and/or decision-makers. Nominations close 10/1/2025.

Calling all psychiatric pharmacist rising stars. Nominate yourself or others for the AAPP Early Practitioner Award designed to recognizes future leaders within AAPP and Psychiatric Pharmacy. Nominations close 10/1/2025.

Click the link for more information!

Click the link for more information!